Hypovolemic phlebotomy, removing 10% of blood before liver surgery, can cut transfusion needs by 50%, offering a safe, ...

Despite a decline in cost-related medication non-adherence among asthma patients, financial hardship continues to impact one ...

Prenatal blood test sometimes hints at cancer in moms-to-be: study - ...

Pilatus Biosciences Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its leading molecule, PLT012, for treating liver and intrahepatic bile ...

LBA-1: Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase III Study (inMIND) SAN DIEGO, Dec. 10, 2024 /PRNewswire/ -- Patients with ...

The global Minimal Residual Disease market is expected to grow to USD 2.55 Billion by 2029, up from USD 1.43 Billion in 2024, at a CAGR of 12.2% over the forecast period. Factors that fuel the growth ...

Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU ...

Options Medical Weight Loss, the nation's premier medical weight loss clinic, is excited to announce its expansion into the Philadelphia Metro area with the opening of two new clinics in Collegeville ...

Novartis today announced results from an updated analysis of the pivotal Phase III NATALEE trial of Kisqali® (ribociclib) that underscore the extended efficacy beyond the duration of treatment in ...

Veterinary Vaccines Market Report Introduction 2 Veterinary Vaccines Market Executive Summary 3 Competitive Landscape ...

The Youth Tracker, developed by Surgo Health with funding from Pivotal and SHOWTIME/MTV Entertainment Studios, reveals new data around the complexity of youth ...

The Neuropathy Action Foundation (NAF), a non-profit organization dedicated to ensuring neuropathy patients have access to the treatments necessary to improve their quality of life, ...